Filter News
Area of Research
- (-) Advanced Manufacturing (1)
- (-) Nuclear Science and Technology (5)
- Biology and Environment (11)
- Clean Energy (34)
- Computer Science (2)
- Isotopes (1)
- Materials (51)
- Materials for Computing (3)
- National Security (7)
- Neutron Science (16)
- Quantum information Science (2)
- Sensors and Controls (1)
- Supercomputing (23)
News Type
News Topics
- (-) Artificial Intelligence (1)
- (-) Bioenergy (1)
- (-) Biomedical (2)
- (-) Materials Science (2)
- 3-D Printing/Advanced Manufacturing (9)
- Advanced Reactors (8)
- Computer Science (2)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Environment (1)
- Fusion (6)
- Isotopes (5)
- Machine Learning (1)
- Molten Salt (4)
- Neutron Science (4)
- Nuclear Energy (22)
- Physics (1)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (4)
Media Contacts
The combination of bioenergy with carbon capture and storage could cost-effectively sequester hundreds of millions of metric tons per year of carbon dioxide in the United States, making it a competitive solution for carbon management, according to a new analysis by ORNL scientists.
Oak Ridge National Laboratory researchers have developed artificial intelligence software for powder bed 3D printers that assesses the quality of parts in real time, without the need for expensive characterization equipment.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
Scientists at the Department of Energy Manufacturing Demonstration Facility at ORNL have their eyes on the prize: the Transformational Challenge Reactor, or TCR, a microreactor built using 3D printing and other new approaches that will be up and running by 2023.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.